Vasculitis: report from Mexico

Kussmaul A, Maier R. Über eine bisher nicht beschreibene eigenthümliche Arterienerkrankung (Periarteriitis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskellähmung einhergeht. Deutsches Arch Klin Med. 1866;1:481–516. Lucio R, Alvarado I. Opúsculo sobre el mal de San Lázaro o elefancíasis de los griegos. In: González-Ureña J, editor. La lepra en México. Buenos Aires: El Ateneo; 1941. p. 199–231. Latapí F, Chévez Zamora A. The “spotted” leprosy of Lucio: an introduction to its clinical and histological study. Int J Lepr. 1948; 16:421–30. Martínez Guzmán M. Cuatro médicos personales del Emperador Maximiliano de Habsburgo. 1864–1867. Bol Mex His Fil Med. 2003: 6:17–22. Rea TH, Ridley TS. Lucio’s phenomenon: a comparative histological study. Int J Lepr. 1979;47:161–6. Vargas-Ocampo F. Diffuse leprosy of Lucio and Latapí: a histologic study. Lepr Rev. 2007;78:248–60. Iglesias-Gamarra A, Coral P, Quintana G, Toro CE, Flores LF, Matteson E, Restrepo JF. History of primary vasculitis in Latin America. Med Sci Monit. 2010: 16:RA58-72. Alarcón Segovia D, Brown AL Jr. Classification and etiologic aspects of necrotizing angiitides: an analytical approach to a confused subject with a critical review of the evidence for hypersensitivity in polyarteritis nodosa. Mayo Clin Proc. 1964; 39:205–22. Zeek PM. Periarteritis nodosa: a critical review. Am J Clin Pathol. 1952;22:777–90. Alarcon-Segovia D. The necrotizing vasculitides. A new pathogenetic classification. Med Clin North Am. 1977;61:241–60. Alarcon-Segovia D. Classification of the necrotizing vasculitides in man. Clin Rheum Dis. 1980;6:223–31. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CGM, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DGI, Specks U, Stone JH, Takahashi K, Watts RA. Revised International Chapel Hill Consensus Conference Nomenclature of the Vasculitides. Arthritis Rheum. 2012 (in press). doi:10.1002/art.37715. Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE. Takayasu’s arteritis. Clinical study of 107 cases. Am Heart J. 1977;93:94–103. Fraga A, Mintz G, Valle L, Flores-Izquierdo G. Takayasu’s arteritis: frequency of systemic manifestations (study of 22 patients) and favorable response to maintenance steroid therapy with adrenocorticosteroids (12 patients). Arthritis Rheum. 1972;15:617–24. Castro G, Chávez-Peón C, Sánchez-Torres G, Reyes PA. HLA-A and B antigens in Takayasu’s arteritis. Rev Invest Clin. 1982;34:15–7. Vargas-Alarcón G, Flores-Domínguez C, Hernández-Pacheco G, Zuñiga J, Gamboa R, Soto ME, Granados J, Reyes PA. Immunogenetics and clinical aspects of Takayasu’s arteritis patients in a Mexican Mestizo population. Clin Exp Rheumatol. 2001;19:439–43. Soto ME, Espínola N, Flores-Suárez LF, Reyes PA. Takayasu arteritis: clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis. Clin Exp Rheumatol. 2008;26:S9–15. Alba MA, Mena-Madrazo JA, Reyes E, Flores-Suárez LF. Giant cell arteritis in Mexican patients. J Clin Rheumatol. 2012;18:1–7. Soto-Vega E, García-Muñoz R, Richaud-Patin Y, Zúñiga-Ramos J, Crispín JC, Dìaz-Jouanen E, Flores-Suárez LF, Llorente L, Granados J. Class I and class II MHC polymorphisms in Mexican patients with Behçet’s disease. Immunol Lett. 2004;93:211–5. Flores-Suárez LF, Villa AR. Spectrum of Wegener granulomatosis in a Mexican population. Ann N Y Acad Sci. 2007;1107:400–9. Flores-Suárez LF. De dificultades, retos y otras enfermedades. Rev Mex Reumat. 2004;3:192–3. Flores-Suárez LF, Gross WL, Guillevin L, Salvarani C. XIII International Vasculitis and ANCA Workshop. Cancún, Mexico, 26–29 April 2007. Foreword. Clin Exp Rheumatol. 2007; 25:S-43.